

share
Dota-(Tyr3)-Octreotate CAS NO 177943-89-4
Unit Price:
CAS No.:177943-89-4
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Dota-(Tyr3)-Octreotate is a synthetic peptide derivative, a key intermediate in the development of targeted radiopharmaceuticals. Its primary value lies in its ability to chelate radionuclides, enabling precise diagnostic imaging and therapeutic applications in nuclear medicine. This compound is essential for pharmaceutical R&D teams and manufacturers specializing in oncology and neuroendocrine tumor treatments, where targeted drug delivery is critical.
Application
- Primary intermediate in the synthesis of Ga-68 DOTA-TATE and Lu-177 DOTA-TATE for targeted radionuclide therapy (TRT).
- Critical precursor for PET (Positron Emission Tomography) imaging agents used in the diagnosis and staging of neuroendocrine tumors.
- Research and development of novel theranostic pairs for personalized cancer treatment.
- Development of peptide receptor radionuclide therapy (PRRT) formulations.
- Conjugation studies for improving radiopharmaceutical stability and biodistribution.
- Reference standard in analytical method development and quality control for peptide-based APIs.
Basic Information
| Product Name | Dota-(Tyr3)-Octreotate |
| CAS No. | 177943-89-4 |
| Molecular Formula | C₆₅H₉₀N₁₄O₁₉S₂ |
| Molecular Weight | 1435.6 g/mol |
| Synonyms | DOTA-TATE; DOTA-(Tyr3)-octreotate; DOTA0-Tyr3-Octreotate; DOTA-Tyr3-Octreotate; (DOTA)0-Tyr3-Octreotate; DOTA-Octreotate; DOTA-TOC; Ga-68 DOTA-TATE precursor; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr3-Octreotate |
| EINECS | Contact for details |
Quality Control
Our Dota-(Tyr3)-Octreotate is manufactured under strict quality management systems. Each batch is subjected to comprehensive analytical testing, including HPLC for purity, MS for identity confirmation, and tests for residual solvents and related substances. We provide full traceability and Certificates of Analysis (COA) are available for every shipment, ensuring compliance with cGMP guidelines for pharmaceutical intermediates.
Storage
Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry environment. This product is hygroscopic (moisture-sensitive). Allow the vial to equilibrate to room temperature in a desiccator before opening to minimize moisture uptake.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (HPLC/MS) | Conforms to reference standard |
| Purity (HPLC) | ≥ 95.0% |
| Single Impurity (HPLC) | ≤ 2.0% |
| Water Content (KF) | ≤ 5.0% |
| Acetate Content (HPLC) | ≤ 10.0% |
| Peptide Content | ≥ 70.0% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Diatrizoate Sodium CAS NO 737-31-5


Iobitridol CAS NO 136949-58-1


Indocyanine Green CAS NO 3599-32-4


Meglumine CAS NO 6284-40-8


Diatrizoic Acid CAS NO 117-96-4


Dimethiodal Sodium CAS NO 124-88-9


Methiodal Sodium CAS NO 126-31-8


Sodium Diprotrizoate CAS NO 129-57-7


Sodium Acetrizoate CAS NO 129-63-5


Meglumine Diatrizoate CAS NO 131-49-7


Ipodate Calcium (200 Mg) CAS NO 1151-11-7


3-[[n-(3-Amino-2,4,6-Triiodophenyl)-n-Methylamino]Carbonyl]Propionic Acid CAS NO 1221-05-2


Ipodate Sodium CAS NO 1221-56-3


Sodium 3-(Acetylamino)-2,4,6-Triiodo-5-[(Methylamino)Carbonyl]Benzoate CAS NO 1225-20-3


Bunamiodyl CAS NO 1233-53-0


3-[3-(Carbamoylmethyl)-2,4,6-Triiodo-Phenyl]Propanoic Acid CAS NO 1456-51-5


Ioprocemic Acid CAS NO 1456-52-6


Sodium 4-(4-Hydroxy-3-Iodophenoxy)-3,5-Diiodophenylacetate CAS NO 1477-04-9


Hydroxyamphetamine CAS NO 1518-86-1


Succinic Acid Mono-3-Amino-2,4,6-Triiodo-n-Ethylanilide CAS NO 1634-73-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






